Comparison of the Effectiveness of Intradialytic Core Stabilization and Aerobic Exercise in Hemodialysis Patients

NCT ID: NCT05534542

Last Updated: 2024-06-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-08-01

Study Completion Date

2022-10-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose: To examine the effects of core stabilization and aerobic exercises on dialysis adequacy, functionality level, and quality of life in hemodialysis (HD) patients. The secondary aim of the study is to compare the effectiveness of intradialytic core stabilization and aerobic exercises in HD patients.

Materials and Methods: Patients who received hemodialysis treatment for 4 hours, 3 days a week were planned to be included in this randomized controlled study. Patients participating in the study will be randomly divided into 2 groups. Grup 1 was planned to be given core stabilization exercises during hemodialysis three times a week for eight weeks; Group 2 was planned to be given aerobic exercise during hemodialysis three times a week for eight weeks. It aimed to evaluate the patients in the weeks before the start of the treatment and the week after the end of the treatment. Personal information form for evaluation, dialysis adequacy, quality of life questionnaire-kidney disease quality of life-36, piper fatigue scale, hospital anxiety and depression scale (hads), Pittsburgh sleep scale, five times sit and stand test, 10 m walking test , tinetti balance and walking test, and 2-minute step test were planned to be used.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemodialysis Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

core stabılızatıon

use of ıntradıalıtıc core stabılızatıon ın hemodıalysıs patıents

Group Type ACTIVE_COMPARATOR

exercıse

Intervention Type OTHER

ıntradıalıtıc core stabılızatıon

aerobıc exercıse

use of ıntradıalıtıc aerobıc exercıse ın hemodıalysıs patıents

Group Type ACTIVE_COMPARATOR

exercıse

Intervention Type OTHER

ıntradıalıtıc core stabılızatıon

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

exercıse

ıntradıalıtıc core stabılızatıon

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* To receive HD treatment for a minimum of 6 months, for 4 hours per day, three days per week
* Being 18 years or older
* A score of 3 and/or below in the Sarcopenia Screening Test (SARC-F)

Exclusion Criteria

* Having a history of myocardial infarction in the last 3 months
* Having angina pectoris, arrhythmia, or uncontrolled hypertension
* Having communication and/or cognitive issues that prevent them from meeting the requirements of the tests
* Becoming pregnant or going through infertility treatment
* Having a psychiatric diagnosis
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Muş Alparslan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cengiz TAŞKAYA

Role: PRINCIPAL_INVESTIGATOR

scholar

Buket Büyükturan

Role: STUDY_DIRECTOR

scholar

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mus State Hospital

Muş, Muş, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

cngztaskaya

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Resistance Exercise in Hemodialysis Patients
NCT06604221 NOT_YET_RECRUITING NA